Middle East and Africa Swine Healthcare Market: By Product Type (Drugs, Feed Products), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections), By Route of Administration (Oral, Parenteral), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Country  

Purchase Option

$ 3100
$ 4600
$ 6900

Middle East and Africa Swine Healthcare Market size was valued at US$ X% Bn in 2022, growing at a significant CAGR of X% from 2023-2029. Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. Swine healthcare becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases. Stringent regulatory guidelines for the swine vaccines and drug approvals, High cost and adverse effects associated with the drugs and Lack of awareness about the swine vaccines and therapeutics in underdeveloped countries are restraints of Middle East and Africa Swine Healthcare Market. This report presents market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. 

Middle East and Africa Swine Healthcare Market Dynamics

Increase in demand for healthy pork meat coupled with rise in production of pork meat, Rise in prevalence of various infectious and foodborne diseases and expansion of business by the market players and Grow in adoption of newer products and development in economic growth are drivers of Middle East and Africa Swine Healthcare Market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Middle East And Africa Swine Healthcare Market Segmentation

By Product Type
  • Drugs
    • Vaccines
    • Antibiotics
    • Antifungals
    • Parasiticides
    • Anti-Viral Drugs
    • Others
  • Feed Products
    • Nutritional Feed
    • Medicated Feed
    • Non-Medicated Feed
By Disease Type
  • Viral Infections
  • Bacterial Infections
  • Parasitic Infection
  • Fungal Infections
By Route of Administration
  • Oral
  • Parenteral
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Pharmacies
  • Online Pharmacies

Frequently Asked Questions

Zoetis , Merck & Co., Virbac , Boehringer Ingelheim Vetmedica , Elanco , Bayer Animal Health ,Ceva Sante Animale, Wilbur-Ellis Feed, LLC, Vetoquinol S.A.

The report covers the countries market data : Saudi Arabia, United Arab Emirates, South Africa

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2. Middle East and Africa Swine Healthcare Market Introduction 
2.1. Middle East and Africa Swine Healthcare Market  - Taxonomy
2.2. Middle East and Africa Swine Healthcare Market  - Definitions
2.2.1.Product Type
2.2.2.Disease Type
2.2.3.Route of Administration
2.2.4.Distribution Channel
2.2.5.Country
3. Middle East and Africa Swine Healthcare Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Middle East and Africa Swine Healthcare Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Middle East and Africa Swine Healthcare Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Drugs
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Feed Products
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Middle East and Africa Swine Healthcare Market  By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Viral Infections
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Bacterial Infections
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Parasitic Infection
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Fungal Infections
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Middle East and Africa Swine Healthcare Market  By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Oral
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Parenteral
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Middle East and Africa Swine Healthcare Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Veterinary Hospitals
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Veterinary Pharmacies,
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Middle East and Africa Swine Healthcare Market  By Country, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. GCC Countries
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. South Africa
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Rest of MEA
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
10.GCC Countries Middle East and Africa Swine Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Drugs
10.1.2.Feed Products
10.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Viral Infections
10.2.2.Bacterial Infections
10.2.3.Parasitic Infection
10.2.4.Fungal Infections
10.3.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Oral
10.3.2.Parenteral
10.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Veterinary Hospitals
10.4.2.Veterinary Pharmacies,
10.4.3.Online Pharmacies
11.South Africa Middle East and Africa Swine Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Drugs
11.1.2.Feed Products
11.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Viral Infections
11.2.2.Bacterial Infections
11.2.3.Parasitic Infection
11.2.4.Fungal Infections
11.3.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Oral
11.3.2.Parenteral
11.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Veterinary Hospitals
11.4.2.Veterinary Pharmacies,
11.4.3.Online Pharmacies
12.Rest of MEA Middle East and Africa Swine Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Drugs
12.1.2.Feed Products
12.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Viral Infections
12.2.2.Bacterial Infections
12.2.3.Parasitic Infection
12.2.4.Fungal Infections
12.3.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Oral
12.3.2.Parenteral
12.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Veterinary Hospitals
12.4.2.Veterinary Pharmacies,
12.4.3.Online Pharmacies
13.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Viral Infections
13.2.2.Bacterial Infections
13.2.3.Parasitic Infection
13.2.4.Fungal Infections
13.3.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Oral
13.3.2.Parenteral
13.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Veterinary Hospitals
13.4.2.Veterinary Pharmacies,
13.4.3.Online Pharmacies
14.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Viral Infections
14.2.2.Bacterial Infections
14.2.3.Parasitic Infection
14.2.4.Fungal Infections
14.3.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Oral
14.3.2.Parenteral
14.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Veterinary Hospitals
14.4.2.Veterinary Pharmacies,
14.4.3.Online Pharmacies
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Zoetis (Pfizer, Inc.) (U.S.)
15.2.2.Merck & Co. Inc. (U.S)
15.2.3.Virbac S.A. (France)
15.2.4.Boehringer Ingelheim Vetmedica (Germany)
15.2.5.Elanco (U.S.)
15.2.6.Bayer Animal Health (Germany)
15.2.7.Ceva Sante Animale (France)
15.2.8.Wilbur-Ellis Feed, LLC (U.S.)
15.2.9.Vetoquinol S.A. (France)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Virbac S.A. (France)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Wilbur-Ellis Feed, LLC (U.S.)
  • Vetoquinol S.A. (France)

Adjacent Markets